Actively Recruiting

Phase 4
Age: 48Months - 69Months
All Genders
NCT04781140

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD

Led by Supernus Pharmaceuticals, Inc. · Updated on 2026-02-18

286

Participants Needed

47

Research Sites

114 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study will evaluate the efficacy and safety of SPN-812 (viloxazine extended release) in children 4 to 5 years of age with ADHD.

CONDITIONS

Official Title

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD

Who Can Participate

Age: 48Months - 69Months
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male or female aged 4 years 0 months to less than or equal to 5 years 9 months at screening and medically healthy
  • Parent or legal guardian able and willing to provide written informed consent
  • Primary diagnosis of ADHD confirmed by DSM-IV-TR and K-SADS-PL
  • ADHD-RS-IV-P Total Score of at least 28 (males) or 24 (females) at screening and baseline
  • Clinical Global Impression-Severity (CGI-S) score of 4 or higher at screening and baseline
  • Has had adequate non-drug treatment or symptoms severe enough to require medication without prior non-drug treatment
  • Participates in structured group activities at least 2 days per week during the study
  • No new behavioral therapy started within 30 days before screening and no planned changes during the study
  • If on ADHD medication at screening with uncontrolled symptoms, must stop medication at least 7 days before baseline
  • No conditions that could affect study results or safety as judged by the investigator
  • Has lived with the same parent(s) or guardian(s) or shared living arrangement for at least 6 months before screening
  • Body weight at or above the 5th percentile for age and sex at screening and baseline
Not Eligible

You will not qualify if you...

  • Diagnosis of another primary psychiatric disorder or comorbid disorder likely to affect study adherence or results
  • Current major neurological disorder or history of seizures or seizure-like events, assessed case-by-case
  • First-degree relative with Bipolar Disorder
  • Global developmental delay or intellectual disability
  • Significant systemic disease per investigator's judgement
  • Body mass index above the 95th percentile for age and sex at screening or baseline
  • Resting blood pressure and pulse rate above the 95th percentile for age, sex, and height at screening or baseline
  • Clinically significant abnormal electrocardiogram at screening
  • Current or prior use of SPN-812 with lack of efficacy or adverse reactions, or allergy to viloxazine
  • Allergy to or inability to swallow pudding, applesauce, or intact capsules
  • Food allergy, intolerance, restriction, or special diet that contraindicates participation
  • Use of investigational drugs within 30 days or 5 half-lives prior to baseline
  • Positive urine drug test at screening (except for amphetamines if on stimulant medication)
  • Use of prohibited medications including known CYP1A2 substrates during screening or study
  • Any other reason judged by the investigator to prevent participation
  • Suicidal ideation or behavior within 6 months prior to screening or lifetime suicide attempt

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 47 locations

1

The Center for Clinical Trials, Inc.

Saraland, Alabama, United States, 36571

Actively Recruiting

2

Preferred Research Partners, Inc.

Little Rock, Arkansas, United States, 72211

Actively Recruiting

3

Advanced Research Center (ARC), Inc.

Anaheim, California, United States, 92805

Actively Recruiting

4

Sun Valley Research Center

Imperial, California, United States, 92251

Actively Recruiting

5

Alliance Research

Long Beach, California, United States, 90807

Actively Recruiting

6

IMMUNOe Research Centers

Centennial, Colorado, United States, 80112

Actively Recruiting

7

Luna Research Center

Coral Gables, Florida, United States, 33134

Actively Recruiting

8

Sarkis Clinical Trials

Gainesville, Florida, United States, 32607

Actively Recruiting

9

Clinical Neuroscience Solutions, Inc.

Jacksonville, Florida, United States, 32256

Actively Recruiting

10

Avantis Clinical Research LLC

Miami, Florida, United States, 33155

Actively Recruiting

11

Hope Research Network, LLC.

Miami, Florida, United States, 33166

Actively Recruiting

12

Medical Research Group of Central Florida

Orange City, Florida, United States, 32763

Actively Recruiting

13

Clinical Neuroscience Solutions, Inc.

Orlando, Florida, United States, 32801

Actively Recruiting

14

APG Research LLC

Orlando, Florida, United States, 32803

Actively Recruiting

15

D&H Tamarac Research Center

Tamarac, Florida, United States, 33321

Actively Recruiting

16

Pediatric Neurology and Epilepsy Specialists

Winter Park, Florida, United States, 32789

Actively Recruiting

17

Advanced Discovery Research LLC

Atlanta, Georgia, United States, 30318

Actively Recruiting

18

Clinical Integrative Research Center of Atlanta

Atlanta, Georgia, United States, 30328

Actively Recruiting

19

CenExcel iResearch, LLC

Decatur, Georgia, United States, 30030

Actively Recruiting

20

CenExel iResearch, LLC.

Savannah, Georgia, United States, 31405

Actively Recruiting

21

Qualmedica Research, LLC.

Evansville, Indiana, United States, 47715

Actively Recruiting

22

Kentucky Pediatric/Adult Research

Bardstown, Kentucky, United States, 40004

Actively Recruiting

23

Qualmedica Research, LLC.

Owensboro, Kentucky, United States, 42301

Actively Recruiting

24

DelRicht Research (Touro Medical Center)

New Orleans, Louisiana, United States, 70115

Actively Recruiting

25

DelRicht Research

Prairieville, Louisiana, United States, 70769

Actively Recruiting

26

Kennedy Krieger Institute

Baltimore, Maryland, United States, 21205

Actively Recruiting

27

Boston Children's Hospital

Boston, Massachusetts, United States, 02445

Actively Recruiting

28

Neurobehavioral Medicine Group

Bloomfield Hills, Michigan, United States, 48302

Actively Recruiting

29

Precise Research Centers

Flowood, Mississippi, United States, 39232

Actively Recruiting

30

Clinical Research of Southern Nevada, LLC.

Las Vegas, Nevada, United States, 89128

Actively Recruiting

31

Med Clinical Research

Irvington, New Jersey, United States, 07111

Actively Recruiting

32

Jersey Shore University Medical Center

Neptune City, New Jersey, United States, 07753

Actively Recruiting

33

Icahn School of Medicine at Mount Sinai

New York, New York, United States, 10028

Actively Recruiting

34

Duke University

Durham, North Carolina, United States, 27705

Actively Recruiting

35

Cincinnati Children's Hospital and Medical Center

Cincinnati, Ohio, United States, 45229

Actively Recruiting

36

CincyScience

West Chester, Ohio, United States, 45069

Actively Recruiting

37

Cyn3rgy Research

Gresham, Oregon, United States, 97030

Actively Recruiting

38

Penn State Health Medical Group - Psychiatry and Behavioral Health

Hershey, Pennsylvania, United States, 17033

Actively Recruiting

39

Coastal Carolina Research Center

North Charleston, South Carolina, United States, 29405

Actively Recruiting

40

Coastal Pediatric Research

Summerville, South Carolina, United States, 29486

Actively Recruiting

41

Clinical Neuroscience Solutions, Inc.

Memphis, Tennessee, United States, 38119

Actively Recruiting

42

Houston Clinical Trials, LLC.

Bellaire, Texas, United States, 77401

Actively Recruiting

43

Javara

Dallas, Texas, United States, 75230

Actively Recruiting

44

AIM Trials, LLC

Plano, Texas, United States, 75093

Actively Recruiting

45

Family Psych of The Woodlands

The Woodlands, Texas, United States, 77381

Actively Recruiting

46

Clinical Research Partners, LLC

Petersburg, Virginia, United States, 23805

Actively Recruiting

47

Virginia Commonwealth University, Virginia Treatment Center for Children

Richmond, Virginia, United States, 23220

Actively Recruiting

Loading map...

Research Team

J

Joseph T Hull, PhD

CONTACT

L

Leslie Brijbasi

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD | DecenTrialz